News

Glass Lewis Advocates for Independent Nominees at Masimo

Glass Lewis Advocates for Independent Nominees at Masimo

Glass Lewis Endorses Change at Masimo Corporation

Recently, Politan Capital Management, which has an 8.9% ownership stake in Masimo Corporation, released a statement noting the renewed support from Glass Lewis, a reputable proxy advisory firm. Glass Lewis has reiterated its earlier recommendation for shareholders to vote in favor of Politan's independent director nominees, Darlene Solomon and Bill Jellison, during the upcoming Annual Meeting.

The Need for Change at Masimo

In their updated report, Glass Lewis expressed ongoing concerns regarding the current governance structure at Masimo. They stated, "We remain decidedly concerned with the efficacy of Masimo's status quo oversight architecture." This highlights their belief that the current board is not effectively overseeing or evaluating critical strategic options for the company, including the proposed separation of historically underperforming areas.

Supporting Politan's Nominees

Glass Lewis recognized Politan's nominees as credible and independent individuals who could better serve the interests of Masimo’s shareholders during this crucial period. Their goal is to ensure that all shareholders feel their perspectives are genuinely taken into account in the company's decision-making process.

Clarifying Misconceptions About Control

In response to Masimo's claims that Politan is trying to take control of the company, Glass Lewis clarified that the aim is simply to transition from a board dominated by CEO Joe Kiani to one with a majority of independent directors. This change is intended to improve governance and accountability within the organization.

Debunking CEO Kiani’s Alarmist Claims

Glass Lewis also dismissed CEO Kiani's concerns about potential disruptions, such as employee departures. They expressed concern that the board was relying more on speculation than on solid facts to evaluate employee sentiment, which raised doubts about the effectiveness of the current board’s management.

Critique of Governance and Strategy Issues

Furthermore, Glass Lewis pointed out that the ongoing litigation in California has revealed several governance shortcomings by Masimo's board. The firm noted that many claims made by Masimo in this context have not held up under scrutiny, underscoring the urgent need for change.

Concerns About Financial Performance

Despite recent statements from management about improved quarterly performance, Glass Lewis argues that this does not justify the current board's strategy. They highlighted that Masimo’s consumer health segment continues to decline, indicating deeper issues that call for immediate and strategic intervention.

Encouraging Action Among Masimo Shareholders

Given these findings, Politan urges Masimo shareholders to take decisive action. They strongly encourage all stockholders, regardless of how many shares they own, to participate in the voting process. The message is to promptly return the WHITE universal proxy cards to support both Solomon and Jellison’s candidacies and to back Politan's strategic agenda for the company.

Getting Involved

Shareholders with questions about the voting process or those needing assistance with proxy materials are urged to reach out to D.F. King & Co., Inc. for guidance and further support. Engaging in this process is vital for shareholders looking to influence the future direction of Masimo.

Frequently Asked Questions

What role does Glass Lewis play in the Masimo situation?

Glass Lewis acts as a proxy advisory firm that provides recommendations and insights for shareholders on corporate governance issues, including director elections.

Who are Politan's board nominees for Masimo?

The nominees are Darlene Solomon and Bill Jellison, proposed by Politan Capital Management for the upcoming board election.

Why does Glass Lewis advise supporting Politan's nominees?

Glass Lewis believes that the current board is not effectively managing Masimo’s strategic options and that Politan’s nominees would better represent the interests of the shareholders.

What actions should shareholders consider taking?

Shareholders are encouraged to vote for Politan's nominees and promptly return their WHITE universal proxy cards to ensure their votes are counted.

How can shareholders get help with their voting?

Shareholders can contact D.F. King & Co., Inc. for assistance with the voting process and any questions related to proxy materials.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading

Top 5 Most Recently Viewed Articles

Velcan Holdings Enhances Share Buyback Program: Weekly Update

Updated Category News Views 146

Velcan Holdings Expands Share Buyback Initiative Velcan Holdings has been actively engaged in a strategic share buyback program, reflecting its commitment to enhance shareholder value. This initiative, governed by a resolution from a shareholders’ meeting, aims to repurchase shares in the market to consolidate the company’s financial stability and improve its stock's...

Continue Reading
Glycolic Acid Market Growth Driven by Skincare Trends

Updated Category News Views 69

Introduction to the Glycolic Acid Market The Glycolic Acid Market is on a path of significant growth, positioning itself as a key player largely influenced by its rising applications in the cosmetic and industrial sectors. This alpha hydroxy acid (AHA) is cherished for its efficacy in skincare, particularly in products such as exfoliants and chemical peels, where it helps...

Continue Reading
World Bank Extends Support to Argentina with $2 Billion Loan

Updated Category News Views 170

World Bank's Major Financial Support for Argentina The World Bank is stepping up its support for Argentina by injecting over $2 billion in new loans. This significant financial assistance is targeted toward vital sectors including social security, education, transportation, and energy. The aim is to tackle pressing issues such as poverty within the nation. Details from...

Continue Reading
Exploring Nu Holdings: Brazil's Fintech Powerhouse Opportunity

Updated Category News Views 189

Unveiling Nu Holdings: Brazil's Fintech Beacon As the final weeks of the first quarter approach, an intriguing shift is evident in the financial landscape. While the benchmark S&P 500 shows less agility compared to numerous foreign markets, Latin American firms stand out as promising investments. This presents an enticing opportunity for those investors looking to...

Continue Reading
Examining NVIDIA's Competitive Edge in Semiconductor Sector

Updated Category News Views 139

Understanding NVIDIA's Market Position In today's fast-paced and highly competitive business environment, investors must evaluate companies closely. This article examines NVIDIA (NASDAQ: NVDA) in depth, providing insights for investors by analyzing its performance against major competitors in the Semiconductors & Semiconductor Equipment sector. By delving into essential...

Continue Reading